Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$813M
Enterprise value$795.1M
Revenue$14.1M +128.2%
True FCF (ex-SBC)$-46.6M +39.1%
Rule of 40-153.3%
ROIC-65.2%
True FCF Yield-5.7%
EPS, diluted$-0.17 +55.3%
Modern Valuation (EOD)
Market Cap$813M
Enterprise Value$795.1M
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales56.46
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book10.62
Owner & Cash Yields
True FCF Yield-5.7%
FCF Yield-4.9%
Owner Earn. Yield-4.9%
Earnings Yield-4.1%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh$-0.26
EPS (diluted)$-0.17
Compounder & Returns
Rule of 40-153.3%
ROIC-65.2%
Cash ROIC (CROIC)-67.7%
GP / Assets—
ROE-43.7%
ROA-35.4%
Gross Margin—
Oper. Margin-271.0%
Net Margin-237.9%
FCF Margin-281.5%
True FCF Margin-330.8%
Quality & Dilution
Cash Conversion—
Accrual Ratio+6.5%
SBC % of FCF—
SBC % of Rev49.4%
Reinvest. Rate—
Sales Growth Y/Y+128.2%
Sales 3Y CAGR−28.8%
EPS Growth Y/Y+55.3%
FCF Growth Y/Y+39.1%
FCF 3Y CAGR—
Share Change Y/Y+3.2%
Balance Sheet & Scale
Revenue (FY)$14.1M
Gross Profit (FY)—
Oper. Income (FY)$-38.2M
GAAP Net Income$-33.5M
True FCF (ex-SBC)$-46.6M
Cash & Equiv$18.0M
Total Debt—
Net Cash (Debt)$18.0M
Net Cash % MCap+2.2%
Debt / FCF (yrs)0.0y
Current Ratio15.73153.29M sh
Price & Technicals (EOD)
Perf Week+0.99%
Perf Month−2.63%
Perf Quarter−21.88%
Perf Half Y−8.33%
Perf YTD−7.29%
SMA 20 Dist+1.02%$4.03
SMA 50 Dist−6.95%$4.37
SMA 100 Dist−11.08%$4.58
Window High−22.03%$5.22
Window Low+11.35%$3.66
RSI (14) · Vol48.052%v
Income Distribution & Cash Flow ConversionHow every dollar of ABUS revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Standard Free Cash Flow (FCF)$-39.6M(-281.5% margin)
Less: Stock-Based Comp (SBC)−$7.0M
True FCF (Owner Cash ex-SBC)$-46.6M(-330.8% of rev)
Revenue by fiscal year
$11.0MFY21
$39.0MFY22
$18.1MFY23
$6.2MFY24
$14.1MFY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$11.0M
$39.0M
$18.1M
$6.2M
$14.1M
+128.2%
+6.4%
Research & Development (R&D)
$65.5M
$84.4M
$73.7M
$54.0M
$25.2M
−53.3%
−21.2%
Total Operating Expenses
$84.5M
$104.5M
$96.2M
$82.5M
$52.2M
−36.7%
−11.3%
Operating Income (EBIT) ▸
$-73.5M
$-65.5M
$-78.1M
$-76.3M
$-38.2M
+50.0%
—
Interest Expense
$2.9M
$1.7M
$459,000
$137,000
$97,000
−29.2%
−57.1%
Income Tax Expense
$0
$4.4M
$0
$0
$0
—
—
GAAP Net Income ▸
$-76.2M
$-69.5M
$-72.8M
$-69.9M
$-33.5M
+52.1%
—
Diluted EPS ▸
$-0.83
$-0.46
$-0.44
$-0.38
$-0.17
+55.3%
—
Diluted Shares
106.2M
150.9M
166.0M
185.6M
191.6M
+3.2%
+15.9%
Balance Sheet
Cash & Equivalents
$109.3M
$30.8M
$26.3M
$36.3M
$18.0M
−50.4%
−36.3%
Total Current Assets
$160.7M
$151.1M
$132.0M
$127.3M
$94.5M
−25.8%
−12.4%
Total Assets
$204.5M
$195.4M
$144.4M
$131.7M
$94.6M
−28.2%
−17.5%
Total Current Liabilities
$11.2M
$32.9M
$22.5M
$15.6M
$6.0M
−61.5%
−14.5%
Total Debt (Short + Long Term)
$0
$0
$0
$0
$0
—
—
Total Liabilities
$35.0M
$58.6M
$38.4M
$34.3M
$18.0M
−47.5%
−15.3%
Stockholders' Equity
$169.4M
$136.9M
$106.0M
$97.4M
$76.6M
−21.4%
−18.0%
Net Cash / (Net Debt)
$109.3M
$30.8M
$26.3M
$36.3M
$18.0M
−50.4%
−36.3%
Invested Capital
$60.2M
$106.1M
$79.7M
$61.0M
$58.6M
−4.0%
−0.7%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-67.5M
$-35.4M
$-85.9M
$-64.8M
$-39.6M
+38.9%
—
Depreciation & Amortization (D&A)
$1.8M
$1.4M
$1.4M
$1.4M
$363,000
−73.7%
−32.5%
Stock-Based Compensation (SBC)
$6.4M
$7.2M
$9.3M
$9.0M
$7.0M
−22.6%
+2.0%
Capital Expenditures (CapEx)
$809,000
$512,000
$1.0M
$182,000
$0
−100.0%
—
Free Cash Flow (FCF) ▸
$-68.3M
$-35.9M
$-86.9M
$-65.0M
$-39.6M
+39.1%
—
True FCF (ex-SBC Owner Cash)
$-74.8M
$-43.0M
$-96.2M
$-74.0M
$-46.6M
+37.1%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
18 big days in a year, and what we hold on each
A big day is a close more than 5.05% from the one before, three times ABUS’s median day (1.68%). On 0 of the 18, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±5.05%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayABUSWhat we hold that dayGroup (median of 4) · each
1 Dec 3, 2025+6.24%
Before our storiesgroup +0.6%, did not move with it
1Dec 3, 2025+6.24%
Before our stories
+0.6% did not move with itABBV +2.6 · MRK +1.2 · JNJ −0.0 · LLY −1.2
2 Dec 15, 2025+5.10%
Before our storiesgroup +1.5%, did not move with it
2Dec 15, 2025+5.10%
Before our stories
+1.5% did not move with itLLY +3.4 · ABBV +1.9 · JNJ +1.2 · MRK −0.0
3 Dec 16, 2025−7.27%
Before our storiesgroup −1.8%, did not move with it
3Dec 16, 2025−7.27%
Before our stories
−1.8% did not move with itJNJ −2.3 · MRK −2.0 · ABBV −1.7 · LLY −0.7
4 Dec 22, 2025+6.55%
Before our storiesgroup +0.5%, did not move with it
4Dec 22, 2025+6.55%
Before our stories
+0.5% did not move with itMRK +3.6 · ABBV +0.5 · LLY +0.5 · JNJ +0.5
5 Jan 13, 2026+5.33%
Before our storiesgroup −0.0%, did not move with it
5Jan 13, 2026+5.33%
Before our stories
−0.0% did not move with itJNJ +1.9 · ABBV +0.3 · LLY −0.3 · MRK −0.8
6 Jan 16, 2026−13.62%
Before our storiesgroup −0.8%, did not move with it
6Jan 16, 2026−13.62%
Before our stories
−0.8% did not move with itMRK −1.9 · ABBV −1.1 · JNJ −0.4 · LLY +0.5
7 Feb 2, 2026+6.30%
Before our storiesgroup +1.4%, did not move with it
7Feb 2, 2026+6.30%
Before our stories
+1.4% did not move with itMRK +2.8 · JNJ +1.5 · ABBV +1.2 · LLY +0.7
8 Feb 3, 2026−6.38%
Before our storiesgroup +0.5%, did not move with it
8Feb 3, 2026−6.38%
Before our stories
+0.5% did not move with itLLY −3.9 · ABBV +0.0 · JNJ +1.0 · MRK +2.2
9 Feb 4, 2026−5.60%
Before our storiesgroup +1.4%, did not move with it
9Feb 4, 2026−5.60%
Before our stories
+1.4% did not move with itABBV −3.8 · JNJ +0.6 · MRK +2.1 · LLY +10.3
10 Feb 5, 2026−5.41%
Before our storiesgroup +1.0%, did not move with it
10Feb 5, 2026−5.41%
Before our stories
+1.0% did not move with itLLY −7.8 · ABBV +0.9 · MRK +1.2 · JNJ +1.4
11 Feb 9, 2026+5.47%
Before our storiesgroup −0.9%, did not move with it
11Feb 9, 2026+5.47%
Before our stories
−0.9% did not move with itABBV −0.1 · JNJ −0.6 · LLY −1.3 · MRK −3.5
12 Mar 12, 2026−8.47%
Before our storiesgroup −0.7%, did not move with it
12Mar 12, 2026−8.47%
Before our stories
−0.7% did not move with itLLY −2.3 · ABBV −1.0 · JNJ −0.4 · MRK −0.3
13 Mar 25, 2026+5.10%
Before our storiesgroup +1.7%, did not move with it
13Mar 25, 2026+5.10%
Before our stories
+1.7% did not move with itMRK +2.6 · JNJ +2.0 · LLY +1.5 · ABBV +1.0
14 Apr 13, 2026+5.30%
Before our storiesgroup −0.9%, did not move with it
14Apr 13, 2026+5.30%
Before our stories
−0.9% did not move with itJNJ −0.2 · ABBV −0.7 · MRK −1.1 · LLY −1.1
15 May 26, 2026+6.67%
Before our storiesgroup −1.5%, did not move with it
15May 26, 2026+6.67%
Before our stories
−1.5% did not move with itLLY −0.0 · ABBV −1.2 · JNJ −1.8 · MRK −2.2
16 Jul 10, 2026−6.61%
Nothing on ABUSgroup −1.0%, did not move with it
16Jul 10, 2026−6.61%
Nothing on ABUSNo ABUS story, brief or results filing in our record that day
−1.0% did not move with itLLY −2.3 · MRK −1.2 · JNJ −0.8 · ABBV −0.7
17 Aug 21, 2026+9.22%
Nothing on ABUSgroup +1.1%, did not move with it
17Aug 21, 2026+9.22%
Nothing on ABUSNo ABUS story, brief or results filing in our record that day
+1.1% did not move with itMRK +2.4 · ABBV +1.2 · JNJ +1.1 · LLY +0.9
18 Nov 5, 2026−9.61%
Nothing on ABUSgroup −2.3%, did not move with it
18Nov 5, 2026−9.61%
Nothing on ABUSNo ABUS story, brief or results filing in our record that day
−2.3% did not move with itLLY −3.8 · MRK −2.3 · ABBV −2.2 · JNJ −1.4
A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in ABUS’s SEC industry; “moved with ABUS” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). ABUS reports before the open, so day 1 is that day’s close. 2 of 4 times, day 6 ended on the same side as day 1.
Reported Mar 23, 2026
day 1+4.25%day 6+1.42%
Reported May 13, 2026
day 10.00%day 6+1.39%
Reported Aug 12, 2026
day 1−1.71%day 6+6.64%
Reported Nov 10, 2026
day 1+2.69%day 6+8.87%
Next report: expected early FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 10 report: +10.48%. Four reports is a small sample.
Each line is ABUS’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
ABUS against four drug peers, a year at 100
ABUS is down 4.6% in a year. Merck is up 40.9%, Johnson & Johnson 33.7%, Eli Lilly 30.5% and AbbVie 21.0%. All four did more. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ABUS’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.